Binding interaction of SGLT with sugar and thiosugar by the molecular dynamics simulation  by Tamura, Yunoshin et al.
Biochimica et Biophysica Acta 1848 (2015) 2799–2804
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemBinding interaction of SGLT with sugar and thiosugar by the molecular
dynamics simulationYunoshin Tamura a, Hiroh Miyagawa a, Tatsusada Yoshida b, Hiroshi Chuman b,⁎
a Chemistry Laboratories, Taisho Pharmaceutical Co. Ltd., 1-403 Yoshino-cho, Kita-ku, Saitama-shi, Saitama 331-9530, Japan
b Institute of Health Biosciences, The University of Tokushima Graduate School, 1-78 Shomachi, Tokushima 770-8505, Japan⁎ Corresponding author.
E-mail address: hchuman@tokushima-u.ac.jp (H. Chum
http://dx.doi.org/10.1016/j.bbamem.2015.08.001
0005-2736/© 2015 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 8 June 2015
Received in revised form 5 August 2015
Accepted 6 August 2015






Bennett's acceptance ratio methodThe human sodium–glucose co-transporter 2 (hSGLT2) is a transporter responsible for reabsorption of glucose in
the proximal convoluted tubule of the kidney. hSGLT2 inhibitors, including luseogliﬂozin, have been developed
as drugs for type 2 diabetes mellitus. Only luseogliﬂozin contains a thiosugar ring in its chemical structure,
while other hSGLT2 inhibitors contain glucose rings. Consequently, we focused on the binding interactions of
hSGLT2 with sugars and thiosugars. We ﬁrst revealed that the binding afﬁnities of thiosugars are stronger than
those of sugars through molecular dynamics simulations of Vibrio parahaemolyticus, sodium–galactose co-
transporter, and humanhSGLT2.We thendemonstrated that Na+dissociates from the protein to the cytoplasmic
solution more slowly in the thiosugar system than in the sugar system. These differences between sugars and
thiosugars are discussed on the basis of the different binding modes due to the atom at the 5-position of the
sugar and thiosugar rings. Finally, as a result of Na+ dissociation, we suggest that the dissociation of thiosugars
is slower than that of sugars.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The human sodium–glucose co-transporter 2 (hSGLT2) is a transport-
er responsible for reabsorption of glucose in the proximal convoluted tu-
bule of the kidney [1]. hSGLT2 inhibitors are a new class of
pharmaceutical agents to treat type 2 diabetes mellitus (T2DM) that
decrease plasma glucose levels by blocking hSGLT2-mediated glucose re-
absorption. Owing to this mechanism, they can correct hyperglycemia
without insulin secretion. Therefore, side effects due to the direct action
of insulin are hardly expected and long-term glycemic control is possible
without overstimulation or fatigue of the pancreatic β-cells [2]. In recent
years, hSGLT2 inhibitors have been developed and released by a number
of pharmaceutical companies [1,3–6]. Luseogliﬂozin [6] is one of the
potent hSGLT2 inhibitors. In spite of similar in vitro IC50 against
hSGLT2, clinical studies have shown that once-daily administration of
luseogliﬂozin lead to signiﬁcant improvement of HbA1c levels at a very
low dose (2.5 mg) [7,8]. From the results of inhibition kinetics and bind-
ing studies of luseogliﬂozin, the dissociation rate of luseogliﬂozin from
hSGLT2 has been reported to be much slower than those of other
hSGLT2 inhibitors such as phlorizin or empagliﬂozin [9–11]. However,
the mechanism causing the dissociation rates difference is not revealed.
The hSGLT2 inhibitory activity is due to hSGLT2 recognizing the
sugarmoiety of the inhibitor instead of glucose because these inhibitors
have common sugar rings [3], glucose or thioglucose, in their chemicalan).structures. Only luseogliﬂozin contains a 5-thioglucose (SGLC) ring,
while others contain glucose (GLC) rings; therefore, we focused on the
interactions of hSGLT2with sugars and thiosugars. Although the tertiary
structure of hSGLT2 is not known, that of the sodium–galactose co-
transporter of Vibrio parahaemolyticus (vSGLT) was recently revealed
[12]. A molecular simulation using the three-dimensional structure
of vSGLT enabled us to obtain atomic level information about the
binding of galactose with vSGLT [13,14]. As well as reported homol-
ogy between vSGLT and hSGLT1 [12], vSGLT shares homology with
hSGLT2 (32% sequence identity, Fig. S1) and has the same function.
Thereby we can apply the interactions of vSGLT with galactose (GAL)
and 5-thiogalactose (SGAL) to hSGLT2.
We conducted amolecular dynamics (MD) simulation for each com-
plex of vSGLT-GAL and vSGLT-SGAL. Furthermore, we built each com-
plex structure of hSGLT2-GLC and hSGLT2-SGLC from that of vSGLT
and conducted MD simulations similarly. Consequently, we found that
thiosugars bind to vSGLT and hSGLT2 stronger and dissociate more
slowly than sugars. We determined that these differences are due to
different binding modes caused by the hydrogen-bonding ability of
the O5 and S5 atoms of sugars and thiosugars (Fig. 1).
2. Methods
2.1. Building a system
To investigate the interactions of sugars and thiosugars with vSGLT
and hSGLT2, we carried out an MD simulation for each vSGLT–GAL,
Fig. 1. Targets for MD simulations.
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simulation of vSGLT, whose crystal structure was available, we con-
structed three-dimensional structures of the complex systems vSGLT,
GAL, lipids, and water. We built a 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) lipid bilayer membrane with an area of
96 Å × 96 Å extending in the XY-direction using the Membrane Builder
module of Visual Molecular Dynamics (VMD) [15]. We inserted the
vSGLT–GAL structure (PDB ID: 3DH4) [12] into the membrane in the
direction determined by the Orientations of Proteins in Membranes
(OPM) database [16] and deleted the lipid molecules that collided
with each other. We added hydrogen atoms to the vSGLT molecule
using the Protonate 3D module in the MOE molecular modeling soft-
ware package [17]. The molecules were placed in a simulation box of
96 Å × 96 Å × 90 Å, to which xyz periodic boundary conditions were
imposed. Na+, Cl−, and TIP3P model water molecules were placed in
the box to correspond to a 150 mM aqueous NaCl solution. Force-ﬁeld
parameters of ff99SB [18], LIPID14 [19], and GAFF [20] with RESP
(HF/6-31G*) [21] were assigned to proteins, membranes, and sugar
molecules, respectively.
To equilibrate the membrane and water molecules, a 10,000 step
structure optimization was performed with position restraints for the
heavy atoms, except for the membrane and water molecules. Subse-
quently, each 0.5 ns MD simulation of NVT and NPT was performed
under the same restraints. The temperature was maintained at 310 K
by the stochastic dynamics algorithm (relaxation time τ= 2 ps) [22].
Pressure was kept at 1 bar by the Berendsen algorithm [23] (relaxation
time = 1 ps compression rate 4.5), which independently scaled the
XY- and Z-directions of the simulation box. The long-range electro-
static interaction was treated using the particle mesh Ewald method
[24]. We used GROMACS 4.5.5 [22] for a series of MD simulations.
In this way, the equilibrated vSGLT–GAL complex system was
obtained (see Fig. 2). By replacing the molecules in this system, weFig. 2. The initial structure of a series of MD simulations obtained by equilibrating mem-
brane and water molecules in the vSGLT–GAL complex system. vSGLT, POPC, and water
molecules are represented as green, blue, and red, respectively.constructed vSGLT–SGAL, hSGLT2–GLC, and hSGLT2–SGLC complex sys-
tems. The hSGLT2 structure was modeled by substituting only amino
acid residues in the sugar binding site of vSGLT (E68G, Q69H, Y87F,
S91A, A259V, N260S). In the current work, MD simulations of the
vSGLT system were focused to obtain probable results, whose crystal
structures were directly available. Binding afﬁnity calculations of
hSGLT2 were conducted to apply to the hSGLT2 system.
2.2. Free energy calculation
We can compare the difference in binding afﬁnities between vSGLT–
GAL and vSGLT–SGAL from the binding free energy ΔΔG= ΔGS− ΔGO,
where ΔGS and ΔGO are the binding free energies of SGAL and GAL,
respectively. Negative ΔΔG indicates that the binding afﬁnity of SGAL
is stronger than that of GAL. ΔΔG was calculated by coupling MD
simulations according to the free energy cycle in Fig. 3. The coupling
MD simulations consisted of the following: (a) introducing coupled
states between GAL and SGAL by mixing Hamiltonians [25] and
(b) estimating free energy differences between neighboring coupled
states by the Bennett acceptance ratio (BAR) method [26]. ΔG(O→ S)
is the conversion free energy from GAL to SGAL and “com” and “aq”
indicate that it takes place in the protein–lipid complex system and
aqueous solution system, respectively.
First, a 100 ns equilibrating MD simulation of vSGLT-GAL was per-
formedwithout position restraints. Subsequently, every 10 ns snapshot
from the trajectorywas extracted and labeled as S01, S02,…, and S10. In
the samemanner, vSGLT–SGAL snapshots S11, S12,…, and S20were ex-
tracted. CouplingMD simulations for free energy calculationswere then
established from those 20 structures. They were independently per-
formed at 11 λ points (λ= 0.0(GAL state), 0.1, 0.2, 0.3, 0.4, 0.5, 0.6,
0.7, 0.8, 0.9, and 1.0(SGAL state)), where λ is a coupling parameter in-
troduced to represent the intermediate states between GAL and SGAL.
ΔG(O→ S, com) was obtained from a series of free energies calculated
by the BAR method. Similar to ΔG(O→ S, com), ΔG(O→ S, aq) was ob-
tained from the hydrated systems of GAL and SGAL without a mem-
brane or vSGLT. Every 0.5 ns snapshot of 5 ns equilibrating MDs was
used for the coupling MDs. For each intermediate state, a 10,000 step
structure optimization and a 0.2 to 0.5 ns NVT MD were carried out
to equilibrate the system. After equilibration, 10 ns and 1 ns NPTFig. 3. Free energy cycle. ΔGO and ΔGS are binding free energies, where O and S represent
GAL and SGAL, respectively. ΔG(O→ S, aq) and ΔG(O→ S, com) are the conversion free
energies fromGAL to SGAL, where “com” and “aq” indicate that they take place in the pro-
tein–lipid complex system and in the aqueous solution system, respectively.
Table 1







vSGLT (GAL/SGAL) −0.59 ± 0.49 −11.61 ± 0.47 −11.01 ± 0.15
hSGLT2 (GLC/SGLC) −0.38 ± 0.60 −10.72 ± 0.60 −10.34 ± 0.08
ΔG(O→ S, com) and ΔG(O→ S, aq) represent the free energy of conversion from sugar to
thiosugar in the complex system and in the aqueous solution system, respectively. They
are related as follows:ΔΔG=ΔG(O→ S, com)−ΔG(O→ S, aq). Values after ± represent
the standard deviations of 20 simulations.
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systems, respectively. ΔΔG for hSGLT2 was calculated in the same
manner.
2.3. Intermolecular interactions by MD
Each 20 ns MD of vSGLT–GAL and vSGLT–SGAL was carried out 10
times to examine the cause of the difference in binding afﬁnities be-
tween GAL and SGAL. Parameters used in the calculation were the
same as those in the equilibratingMD. For each MD, the interaction en-
ergies between the sugar binding site of vSGLT and sugar molecules
were calculated, where the binding site was deﬁned by amino acid res-
idues within 4.5 Å from GAL in the initial structure. We also calculated
the ratio of hydrogen bond formation (HB ratio) of GAL and SGAL to re-
veal the relationship between the bindingmode and interaction energy.
The HB ratio is also deﬁned as the average number of hydrogen bonds
[22].
2.4. Dissociation of Na+ and movement of trans-membrane helices
To analyze the dissociation of Na+ bound to vSGLT occurring prior to
dissociation of sugar [13,14], the number of dissociation times and the
retention time (the time to dissociation) were calculated. Trajectories
of vSGLT–GAL and vSGLT–SGAL obtained from the previous section
were used for this analysis. We determined the dissociation of Na+ by
the root mean square deviation (RMSD) of Na+ from the initial struc-
ture, where the threshold was set to 20 Å. Trans-membrane helicesFig. 4. Interaction energies of GAL and SGAL divided by their binding site residue. (A) Electrostat
of 10 simulations.TM1, TM5, and TM8 [27] constitute a Na+ binding site. The effect of dis-
placement of these helices to Na+ dissociationwas discussed based on a
principal component analysis (PCA) of Cα atoms [28]. Each snapshot
before dissociation was used in PCA, whose TM2 and TM7 were
superimposed on the X-ray crystal structure.
3. Results and discussion
3.1. Binding afﬁnity and molecular interaction
Calculated binding free energy differences (ΔΔG) with respect
to vSGLT and hSGLT2 are listed in Table 1. ΔΔG of both vSGLT and
hSGLT2 were negative, i.e., binding afﬁnities of S-substituted sugars
were stronger than those of non-substituted sugars. To determine the
cause of the difference in calculated binding afﬁnities, the 20 ns MD of
vSGLT–GAL and vSGLT–SGALwere conducted 10 times. The intermolec-
ular interactions of vSGLT with GAL and SGAL were then divided into
contributions from residues in the sugar binding site. Fig. 4(A) and (B)
shows that, in general, the intermolecular electrostatic interactions
were stronger than vanderWaals interactions. In particular, the electro-
static interactions with GLU88 were strong for both GAL and SGAL. Al-
though the interactions of SGAL with GLN428 and ASN260 were weak
when compared with those of GAL, the interactions of SGAL with
GLU68 and GLU88 weremuch stronger. Therefore, the stronger binding
afﬁnity of SGAL than that of GAL was due to electrostatic interactions
with GLU68 and GLU88. To explain the cause of such differences from
the chemical structure of GAL and SGAL, we analyzed the hydrogen
bonds which GAL and SGAL form in the binding site. GAL and SGAL
formed a number of hydrogen bonds to the binding site through their
hydroxyl groups. HB ratios that described characteristic binding interac-
tions are listed in Table 2. Typical snapshots are also shown in Fig. 5.We
can regard a hydrogen bond with a large HB ratio as a strong hydrogen
bond. Therefore, we found that interactions of GLU88 with O2 atoms of
both GAL and SGAL (see in Fig. 1) weremainly responsible for the bind-
ing afﬁnity, as their HB ratios were large. While O5 and O6 of GAL form
hydrogen bondswith the side chain of GLN428, those of SGAL do not, as
the hydrogen bonding potential of S5 is less than that of O5 [29].
Conversely, HB ratios of O1, O2, and O3 with vicinal residues such
as GLU68 and GLU88 were large. We found that the difference inic interactions and (B) van derWaals interactions. Error bars represent standard deviations
Table 2
Ratio of hydrogen bond formation.
Atom 1 Atom 2 GAL SGAL
O1 GLU68_OE 0.08 ± 0.31 0.63 ± 0.29
O2 GLU88_OE 0.97 ± 0.07 1.07 ± 0.13
O3 GLU88_OE 0.24 ± 0.33 0.67 ± 0.25
O5 or S5 GLN428_NE 0.64 ± 0.32 0.00 ± 0.00
O6 GLN428_OE 0.59 ± 0.29 0.04 ± 0.02
Atom 1 and Atom 2 are the atoms in the sugar ring and amino acid residue of vSGLT, re-
spectively. The name of Atom 2 is composed of the residue name, element, and atom at
the residue. Values after ± represent the standard deviations of 10 simulations.
Table 3
Na+ release in 20 ns MD of vSGLT–GAL and vSGLT–SGAL systems.
vSGLT–GAL vSGLT–SGAL
Number of trials 10 10
Number of times of Na+ release 6 5
Average Na+ retention time (ns) a 4.8 ± 2.7 9.3 ± 5.0
a Retention times were calculated from the MD trajectories that Na+ were released.
Values after ± represent the standard deviations.
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binding mode. Therefore, we deduced that the binding afﬁnity of SGAL
with vSGLT is stronger than that of GAL.
3.2. Relationship between Na+ dissociation andmotion of trans-membrane
helices
Na+ in the vSGLT crystal structure has been reported to dissociate
several nanoseconds after the beginning of an MD simulation [13,14].
It has also been reported that GAL dissociates at approximately 100 ns
with a gate-like, side-chain motion of TYR263 [14]. Conversely, another
group has reported that complete release of GAL does not occur, but
signs of dissociation are observed [13]. Furthermore, they have pro-
posed a gate-free pathway for GAL release from the free energy calcula-
tion by Steered MD [30]. During the time ranges that we calculated,
20 ns and 100 ns, we did not observe dissociation of sugars or its signs
reported in the literature; however, we did observe dissociation of
Na+. Therefore, we focused on Na+, which dissociated prior to GAL re-
lease. Speciﬁcally, in cases of equilibratingMD simulations prior to free-
energy calculations, the vSGLT–SGAL system retainedNa+ to its binding
site for more than 100 ns, while the vSGLT–GAL system released Na+
after retaining Na+ for 5.4 ns (Fig. S2). To discuss the dissociation rate
directly fromMD simulations, multiple longer calculationswould be re-
quired to conﬁrm the reproducibility of the trajectories. We analyzed
the trajectories used in the intermolecular analysis in the previous sec-
tion. The retention time and number of dissociated Na+ ions are sum-
marized in Table 3.
We found that Na+ was not always released in several nanoseconds
as reported butwas stably bound to the binding site for 20 ns. The num-
ber of times Na+ that was released was less in the vSGLT–SGAL system
than that for the vSGLT–GAL system. Moreover, the Na+ retention time
of the vSGLT–SGAL system was longer than that of the vSGLT–GAL
system. Accordingly, we considered that the dissociation rate of
SGAL was slower than that of GAL. Non-availability of precious 3D
structure of hSGLT2 prevents detailed discussion about hSGLT2–
GLC and hSGLT2–SGLC systems. Nevertheless, in equilibrating MDFig. 5. Typical snapshots ofMD simulations. (A) vSGLT–GAL complex at 11,130 ps and (B) vSGLT
GLN428, while those of SGAL do not. O2 and O4 of SGAL form hydrogen bonds with side-chains
binding site in vSGLT. Substrates are transported from upper side to lower side.simulations of hSGLT2 system, we observed that the hSGLT2–SGLC
system retains Na+ for 57.2 ns, whereas that of the hSGLT2–GLC system
retains Na+ for 13.1 ns. Detail proﬁles of the Na+ displacement in
the hSGLT2–GLC and hSGLT2–SGLC systems were shown in Fig. S2.
Thiosugar systems (vSGLT–SGAL and hSGLT2–SGLC) seem to retain
Na+ for longer time than sugar systems (vSGLT–GAL and hSGLT2–GLC).
We observed that Na+must be surrounded bywatermolecules to be
carried away from the binding site. Water molecules are brought to the
binding site by movement of trans-membrane helices TM1, TM5, and
TM8, resulting in the binding site becoming wider. To discuss how the
difference between GAL and SGAL affects such protein motions, we car-
ried out PCA for the displacement of Cα until Na+ dissociation. Fig. 6
shows the collectivemotions corresponding to the primary and second-
ary PC axes. The projections of vSGLT–GAL and vSGLT–SGAL trajectories
on PC axes are shown in Fig. 7. We found a clear difference among the
trajectories. First, the contribution of the primary eigenvalue of PCA is
21%. The positive direction of this eigenvector includes the motion of
GLN428 separating from O5 and S5, as shown in Fig. 6(A). We observed
suchmotionmany times in the vSGLT–SGAL system,whose HB ratio be-
tween GLN428 and S5 is low (Table 2). Second, the contribution of the
secondary eigenvalue is 14%. The positive direction of this eigenvector
corresponds to the TM8 motion narrowing the Na+ binding site, as
shown in Fig. 6(B). This motion represents the approach of GLU88 to
O1. This collective motion is also observed many times in the vSGLT–
SGAL system, whose HB ratio between GLU68 and O1 is high. In con-
trast, TM8 moved in the direction in which the Na+ binding site be-
comes wider in the vSGLT–GAL system, whose HB ratio between
GLU68 and O1 is low. From the difference in motions related to the
size of the Na+ binding site, Na+ dissociates more slowly in the
vSGLT–SGAL system than the vSGLT–GAL system. Thus, Na+ dissocia-
tion could be explained from the difference in binding modes due to
O5 and S5. We concluded that the subsequent dissociation of SGAL
also occurs more slowly than that of GAL.
3.3. Application to hSGLT2
Commercially available hSGLT2 inhibitors inhibit hSGLT2 with high
potency and selectivity [8]. In spite of similar in vitro IC50 against–SGAL complex at 15,060 ps. O5 andO6of GAL formhydrogenbondswith the side-chain of
of GLU68 and GLU88, respectively, while those of GAL do not. (C) The location of the sugar
Fig. 6. Collectivemotions obtained from the principal component analysis corresponding to (A) the primary PC axis and (B) the secondary PC axis. Yellow cones represent eigenvectors of
their eigenvalues.
2803Y. Tamura et al. / Biochimica et Biophysica Acta 1848 (2015) 2799–2804hSGLT2, clinical studies have shown that once-daily administration of
luseogliﬂozin lead to signiﬁcant improvement of HbA1c levels at a
very low dose (2.5 mg) [7,8]. In fact, luseogliﬂozin has been set to the
lowest effective dose (2.5 mg) among hSGLT2 inhibitors launched in
Japan [31]. Recent inhibition kinetics and binding studies of
luseogliﬂozin have shown that the dissociation of luseogliﬂozin from
hSGLT2 appears to be much slower than those of other hSGLT2 inhibi-
tors [9]. Luseogliﬂozin also exhibits a high afﬁnity for hSGLT2 [9].
These proﬁles of luseogliﬂozin might contribute to the long duration
of the drug action although the thorough mechanism of binding is not
revealed [9]. Since vSGLT shares homology with hSGLT2 and has the
same function as hSGLT2, similar discussion about vSGLT is likely appli-
cable to hSGLT2. Our hSGLT2 tertiary structure is no more than the
model substituted with only amino acid residues in the sugar binding
site of vSGLT. This prevents direct and meaningful discussion using
MD simulations. However, we obtained a similar tendencywith binding
afﬁnity (Section 3.2.) and Na+ dissociation (Section 3.3.). It seemed that
such bindingmechanisms of sugars and thiosugars affect the binding af-
ﬁnity and dissociation rate of hSGLT2 inhibitors. It possibly relates to
luseogliﬂozin, which has a unique thiosugar ring.Fig. 7. The projection ofMD trajectories to dominant PC axes. Red and black dots represent
vSGLT–GAL and vSGLT–SGAL trajectories, respectively.4. Conclusion
We found that the binding afﬁnity of SGAL is stronger than that of
GAL through free energy calculations. The Na+ dissociation, which
occurs prior to sugar dissociation, was found to be slower in the SGAL
system, leading to the conclusion that SGAL also dissociatesmore slowly
than GAL. The current analyses of intermolecular interactions as well as
dominant collective motions reasonably explain the difference in
binding afﬁnities and dissociation rates between O5 and S5 from their
binding modes.
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